🟢 Iovance Biotherapeutics is trading 9.45% up in after-hours trading — no confirmed company-specific catalyst

Iovance Biotherapeutics is trading up 9.45% in after-hours trading at $16.21, with no confirmed company-specific announcement explaining the move.

• The October 28 regular-session close was $14.81.
• Recent company news includes October 26 ESMO clinical data and a scheduled November 5 earnings report; available information does not establish either as the direct cause of the after-hours rise.